The BMT Data Book: Including Cellular Therapy

This is an essential guide to the data, basic science, outcome studies and decision-making processes involved in blood and marrow stem cell transplantation. Organized according to disease types and procedures, it contains more than 100 tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between different types of chemotherapy, autologous vs. allogeneic transplantation, peripheral blood vs. bone marrow stem cells, and standard vs. experimental treatments. This new edition summarizes the research of the last four years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndrome and Hodgkin and non-Hodgkin lymphomas. New chapters discuss global trends in stem cell transplantation, cellular therapies including donor lymphocytes, and pediatric neurologic and metabolic disorders. With an expanded complications section, links to electronic databases and discussion of new drugs and alternative stem cell sources, this text belongs in every transplant unit.

Reinhold Munker, MD is Associate Professor of Medicine, Department of Medicine, Division of Hematology-Oncology, Louisiana State University, Shreveport, LA, USA.

Gerhard C. Hildebrandt, MD is Associate Professor of Medicine, Department of Medicine, Division of Hematology-Oncology, Louisiana State University, Shreveport, LA, USA.

Hillard M. Lazarus, MD is a Disease Team Leader, Division of Hematology-Oncology, University Hospitals Case Medical Center, Cleveland, OH, USA.

Kerry Atkinson, MD, FRCP, FRACP is Professor of Medicine, Division of Hematology-Oncology, University of Queensland, and Head, Stem Cell Biology, Regenerative Medicine and Novel Therapeutic Anti-Cancer Agents Group, Mater Medical Research Institute, Queensland, Australia.